Boston Scientific likely misses guidance after August cyberattack disruption

Boston Scientific said it likely won’t meet its financial guidance due to the August cyberattack, which has disrupted medical-device manufacturing and shipping. Operations aren’t fully restored; the company expects to fall short of sales and adjusted per-share results.